Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Journal of Medicinal Chemistry
|
September 13, 2023
Developing a Ruthenium(III) Complex to Trigger Gasdermin E-Mediated Pyroptosis and an Immune Response Based on Decitabine and Liposomes: Targeting Inhibition of Gastric Tumor Growth and Metastasis
Wenjuan Li, Shanhe Li, Gang Xu, et al.
Molecular Pharmaceutics
|
February 26, 2020
Human Serum Albumin-Based Dual-Agent Delivery Systems for Combination Therapy: Acting against Cancer Cells and Inhibiting Neovascularization in the Tumor Microenvironment
Zhenlei Zhang, Juzheng Zhang, Ming Jiang, et al.
Journal of Medicinal Chemistry
|
March 24, 2026
Developing a Multitargeted Anticancer Bi-Copper(II)-Centered Thiocarbohydrazone Agent Based on Lys-199 and His-242 Residues in the IIA Subdomain of Human Serum Albumin
Shanhe Li, Xiaojun Wang, Ming Jiang, et al.
Journal of Medicinal Chemistry
|
April 16, 2021
Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer
Yi Gou, MeiRong Chen, Shanhe Li, et al.
Journal of Medicinal Chemistry
|
May 23, 2023
Developing a Gadolinium(III) Compound Based on Apoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy of Cancer
Xueyu Man, Tongfu Yang, Wenjuan Li, et al.
Journal of Medicinal Chemistry
|
November 13, 2020
Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis
Juzheng Zhang, Zhenlei Zhang, Ming Jiang, et al.
Journal of Medicinal Chemistry
|
March 29, 2024
Developing a Copper(II) Isopropyl 2-Pyridyl Ketone Thiosemicarbazone Compound Based on the IB Subdomain of Human Serum Albumin-Indomethacin Complex: Inhibiting Tumor Growth by Remodeling the Tumor Microenvironment
Xueyu Man, Shanhe Li, Gang Xu, et al.
Journal of Medicinal Chemistry
|
September 19, 2024
Developing a Rhodium(III) Complex to Reprogram the Tumor Immune and Metabolic Microenvironments: Overcoming Multidrug Resistance and Metastasis in Non-Small Cell Lung Cancer
Wenjuan Li, Shanhe Li, Minghui Zhu, et al.
Angewandte Chemie (International Ed. in English)
|
September 19, 2024
Anticancer Tetranuclear Cu(I) Complex Catalyzes a Click Reaction to Synthesize a Chemotherapeutic Agent in situ to Achieve Targeted Dual-Agent Combination Therapy for Cancer
Xueyu Man, Wenjuan Li, Minghui Zhu, et al.
Journal of Medicinal Chemistry
|
March 24, 2022
Developing a Novel Indium(III) Agent Based on Human Serum Albumin Nanoparticles: Integrating Bioimaging and Therapy
Zhenlei Zhang, Tongfu Yang, Juzheng Zhang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Journal of Medicinal Chemistry
|
September 13, 2023
Developing a Ruthenium(III) Complex to Trigger Gasdermin E-Mediated Pyroptosis and an Immune Response Based on Decitabine and Liposomes: Targeting Inhibition of Gastric Tumor Growth and Metastasis
Wenjuan Li, Shanhe Li, Gang Xu, et al.
Molecular Pharmaceutics
|
February 26, 2020
Human Serum Albumin-Based Dual-Agent Delivery Systems for Combination Therapy: Acting against Cancer Cells and Inhibiting Neovascularization in the Tumor Microenvironment
Zhenlei Zhang, Juzheng Zhang, Ming Jiang, et al.
Journal of Medicinal Chemistry
|
March 24, 2026
Developing a Multitargeted Anticancer Bi-Copper(II)-Centered Thiocarbohydrazone Agent Based on Lys-199 and His-242 Residues in the IIA Subdomain of Human Serum Albumin
Shanhe Li, Xiaojun Wang, Ming Jiang, et al.
Journal of Medicinal Chemistry
|
April 16, 2021
Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer
Yi Gou, MeiRong Chen, Shanhe Li, et al.
Journal of Medicinal Chemistry
|
May 23, 2023
Developing a Gadolinium(III) Compound Based on Apoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy of Cancer
Xueyu Man, Tongfu Yang, Wenjuan Li, et al.
Journal of Medicinal Chemistry
|
November 13, 2020
Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis
Juzheng Zhang, Zhenlei Zhang, Ming Jiang, et al.
Journal of Medicinal Chemistry
|
March 29, 2024
Developing a Copper(II) Isopropyl 2-Pyridyl Ketone Thiosemicarbazone Compound Based on the IB Subdomain of Human Serum Albumin-Indomethacin Complex: Inhibiting Tumor Growth by Remodeling the Tumor Microenvironment
Xueyu Man, Shanhe Li, Gang Xu, et al.
Journal of Medicinal Chemistry
|
September 19, 2024
Developing a Rhodium(III) Complex to Reprogram the Tumor Immune and Metabolic Microenvironments: Overcoming Multidrug Resistance and Metastasis in Non-Small Cell Lung Cancer
Wenjuan Li, Shanhe Li, Minghui Zhu, et al.
Angewandte Chemie (International Ed. in English)
|
September 19, 2024
Anticancer Tetranuclear Cu(I) Complex Catalyzes a Click Reaction to Synthesize a Chemotherapeutic Agent in situ to Achieve Targeted Dual-Agent Combination Therapy for Cancer
Xueyu Man, Wenjuan Li, Minghui Zhu, et al.
Journal of Medicinal Chemistry
|
March 24, 2022
Developing a Novel Indium(III) Agent Based on Human Serum Albumin Nanoparticles: Integrating Bioimaging and Therapy
Zhenlei Zhang, Tongfu Yang, Juzheng Zhang, et al.
Page
of 3